---
figid: PMC9440249__12276_2022_837_Fig10_HTML
figtitle: E-375i elicited anti-PCa effects
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC9440249
filename: 12276_2022_837_Fig10_HTML.jpg
figlink: /pmc/articles/PMC9440249/figure/Fig10/
number: F10
caption: Shown is the graphical illustration of the identified pathway of miR-375
  in regulating PCa progression and enzalutamide resistance.
papertitle: MicroRNA-375 is a therapeutic target for castration-resistant prostate
  cancer through the PTPN4/STAT3 axis.
reftext: Junqing Gan, et al. Exp Mol Med. 2022 Aug;54(8):1290-1305.
year: '2022'
doi: 10.1038/s12276-022-00837-6
journal_title: Experimental & Molecular Medicine
journal_nlm_ta: Exp Mol Med
publisher_name: Nature Publishing Group UK
keywords: miRNAs | Prostate cancer
automl_pathway: 0.936506
figid_alias: PMC9440249__F10
figtype: Figure
redirect_from: /figures/PMC9440249__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9440249__12276_2022_837_Fig10_HTML.html
  '@type': Dataset
  description: Shown is the graphical illustration of the identified pathway of miR-375
    in regulating PCa progression and enzalutamide resistance.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIR375
  - PTPN4
  - STAT3
  - AR
  - BCL2
  - PARP1
  - MMP7
  - MMP9
---
